Navigation Links
CEL-SCI Presents Long-Term Cancer Survival Data With Multikine

Multikine Improves Overall Survival by 33% 3.5 Years Post Surgery

VIENNA, Va., May 21, 2007 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION announced today that its cancer drug Multikine(R) was shown to significantly increase long term overall survival in a Phase II study of head and neck cancer patients. The data were presented on May 20, 2007 at the First International Congress of the International Association of Oral Oncology in Amsterdam, the Netherlands, by Dr. Eyal Talor, Senior VP of Research and Manufacturing at CEL-SCI Corporation.

Dr. Talor's presentation focused on the results obtained in CEL-SCI's final Phase II clinical trial of Multikine that was conducted in patients with head and neck cancer (oral squamous cell carcinoma -- OSCC). This final Phase II clinical trial was designed to assess thoroughly the positive safety and efficacy observations made in patients treated with Multikine in CEL-SCI's early Phase II trials. In the trial Multikine was given prior to standard care to recently diagnosed and not yet treated cancer patients.

The addition of Multikine to the first treatment (standard of care) of these patients resulted in a 33% improvement in the median overall survival at 3-1/2 years post-surgery, when compared to the survival results reported in 55 OSCC clinical trials published in the scientific literature between 1987 and 2007.

Multikine first-line treatment also resulted in an improvement of the 2- year local regional over the published local regional control rate. It is clinically recognized that recurrence of disease in head and neck cancer is associated with a very poor prognosis. Multikine treatment did not result in any severe adverse events (SAE) in this Phase II clinical trial and no SAEs related to Multikine have been reported in other trials conducted with Multikine either.

CEL-SCI received clearance from the United States Food and Drug Administration
'"/>




Page: 1 2 3

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: CEL SCI Presents Long Term Cancer Survival Data With Multikine
(Date:11/19/2009)..., LYON, France, Nov. 19 In respo...ying dangerous and illegal medicines, Operation Pa...y INTERPOL and the World Health Organization,s Int...skforce (IMPACT) to highlight the dangers of buyin...tiative resulted in a series of arrests and the se...
(Date:11/19/2009)..., ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstC...NYSE: ABT ) as one of its Most Admired Corporate... Deal honored Abbott as its Most Admired Dealmake...ic use of acquisitions and divestitures since Janu...eshaped its business portfolio with a focus on hig...
(Date:11/19/2009)..., NEWPORT NEWS, Va., Nov. 19 Bre...g (BSGI/MBI) has been recognized and endorsed by t...inst breast cancer: The Society of Breast Imaging ...ocieties published articles supporting the further...gy for the early detection of breast cancer. ,,...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Obese Get Higher Doses of Radiation for X Rays 50432 1Obese Get Higher Doses of Radiation for X Rays 50432 2Obese Get Higher Doses of Radiation for X Rays 50432 3Police work undermines cardiovascular health comparison to general population shows 50430 1Police work undermines cardiovascular health comparison to general population shows 50430 2Police work undermines cardiovascular health comparison to general population shows 50430 3Caregivers may benefit from adult day care 50428 1Caregivers may benefit from adult day care 50428 2
..., June 23 Canopus BioPharma, Inc.,(OTC: CBIA), is...nes,Control Council has granted approval for a Pha...rotective effect of CB1400 on the,gastrointestiona... trial is,an important step forward in the develop...itis agent., Oral and gastrointestinal (GI) mucos...
... Calif., June 23 DaVita Inc., a leading,provider ...hronic kidney,failure and disease (CKD), recently ...ommunity-based workshops that encourage CKD patien...ed decisions about their,dialysis care., (Logo: ...ALOGO ), Available in more than 40 locations thro...
Other Medicine Technology:CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck 2DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 2DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 3
(Date:11/20/2009)...thinks it,s as short as 34 weeks, potentially addi... , FRIDAY, Nov. 20 (HealthDay News) -- Recent re...tinues to climb in the United States. Now, a new ...used about what constitutes a full-term birth in t...ers surveyed in the study considered a baby born a...
(Date:11/20/2009)...u activity remains high and is expected to continu...hDay News) -- Some areas of the United States are ...ral health official said Friday, and while the dis...from the 46 states reported last week. , "We ar...vity around the country, but there is still a lot ...
(Date:11/20/2009)..., SPRINGFIELD, Mo., Nov. 20 Miss...ntral Missouri regions will now have the option to...reached Tuesday between Missouri Consolidated Heal... The Southwest and South Central Missouri regions ...ar, Christian, Dade, Dallas, Douglas, Greene, Hick...
(Date:11/20/2009)..., BATON ROUGE, La., Nov. 20 /PRNewswire-USNews...ns (LAHP) today warned that Louisianians could exp...nefits if proposals being considered by Congress s...ief executive officer for LAHP, "Louisiana health ...orm since the beginning of the national debate. O...
(Date:11/20/2009)..., LANSING, Mich., Nov. 20 /PRNewswire-USNewswire... seven Americans struggled to get enough food to e...culties of older adults who are rapidly aging into...eath of a spouse or divorce mean many have incomes...housing and medicine. Older women are particularl...
Breaking Medicine News(10 mins):Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2
...d by the super bug Clostridium difficile (C diff),...ave of the hospital infection, researchers say. ... that is present naturally in the gut of around 3%...h conditions can interfere with the balance of goo...
...bout wanting to kick the butt, but the seldom turn...quit smoking. The news comes from public ...t Chicago, who conducted study on young adults' sm...ertain proven treatments to help them quit smoking...
...ency and less than 2% incontinence are the strikin...n received an innovative treatment for prostate c...nation with an innovative new image-guidance techn.... Conventional Therapy vs, HDR Brachytherap...
...Vitamin C such as papaya, oranges and blackcurrant...found that the nutrient could help reduce some of... Researchers from the University of Warwick have ...d Vitamin C 'normalises' their levels in the body,...
...nd smoke-free work environment play key roles in h...y from cigarettes, a study has found. The...versity, who also found that environmental factors...king cessation attempts often are thought of as so...
...t stress is our ability to choose one thought over... ... James Stress who has ever escaped its clu...ything. Stress is a demand on the physical...
Other Medicine News:Health News:Probiotic Drinks can Stave Off Hospital Infection 2Health News:Young Adults Seldom Try Proven Methods to Kick the Butt 2Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 2Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 3Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 4Health News:Smoke-free Workplace, Non-smoking Spouse Help Quitters Stay Off the Butt 2Health News:Living With Stress 2Health News:Living With Stress 3Health News:Living With Stress 4
Near PT Test Card/ILLUS of The Ocular Adnexa - BC2208
Near Point Diagnostic Card Set - BC11982
... to be a corrected Rosenbaum card. The known inacc...orton and Jones in 1997 and others) have been corr...he lack of standards associated with this notation...easure a patients single letter near acuity and re...
11970R Standard Reading Test
Medicine Products: